KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $16.16 $18.63 Friday, 26th Apr 2024 ACAD stock ended at $16.71. This is 2.45% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.92% from a day low at $16.27 to a day high of $16.74.
90 days $16.16 $27.94
52 weeks $16.16 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Mar 07, 2016 $21.76 $21.76 $21.76 $21.76 2 096 400
Mar 04, 2016 $21.20 $21.20 $21.20 $21.20 2 230 300
Mar 03, 2016 $21.46 $21.46 $21.46 $21.46 2 462 800
Mar 02, 2016 $20.36 $20.36 $20.36 $20.36 2 492 600
Mar 01, 2016 $19.15 $19.15 $19.15 $19.15 2 723 900
Feb 29, 2016 $17.26 $17.26 $17.26 $17.26 2 204 700
Feb 26, 2016 $18.73 $18.73 $18.73 $18.73 1 733 600
Feb 25, 2016 $18.48 $18.48 $18.48 $18.48 1 741 600
Feb 24, 2016 $19.12 $19.12 $19.12 $19.12 1 877 600
Feb 23, 2016 $19.19 $19.19 $19.19 $19.19 1 476 000
Feb 22, 2016 $20.12 $20.12 $20.12 $20.12 1 709 900
Feb 19, 2016 $19.76 $19.76 $19.76 $19.76 1 732 300
Feb 18, 2016 $19.22 $19.22 $19.22 $19.22 2 021 600
Feb 17, 2016 $20.62 $20.62 $20.62 $20.62 2 603 900
Feb 16, 2016 $18.82 $18.82 $18.82 $18.82 2 052 200
Feb 12, 2016 $18.26 $18.26 $18.26 $18.26 2 398 500
Feb 11, 2016 $17.55 $17.55 $17.55 $17.55 2 158 300
Feb 10, 2016 $18.23 $18.23 $18.23 $18.23 1 567 600
Feb 09, 2016 $18.48 $18.48 $18.48 $18.48 2 098 300
Feb 08, 2016 $17.76 $17.76 $17.76 $17.76 2 391 000
Feb 05, 2016 $19.36 $19.36 $19.36 $19.36 2 651 900
Feb 04, 2016 $20.29 $20.29 $20.29 $20.29 2 867 200
Feb 03, 2016 $18.89 $18.89 $18.89 $18.89 3 020 200
Feb 02, 2016 $19.04 $19.04 $19.04 $19.04 2 297 600
Feb 01, 2016 $20.86 $20.86 $20.86 $20.86 2 661 500
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT